Navigation Links
Serious Eye Disease Gives Birth to Invention of Major New Eye Care Device

ORLANDO, Fla., Feb. 23, 2011 /PRNewswire/ -- The Eye-POD-Eye-Care-Kit was created by a Doctor who suffered a serious eye malady, Bells-Palsy. Inventor Dr. Courtenay created the Eye~POD™ to answer his struggles with dry eyes, a side effect of Bells-Palsy. The affliction was caused by scratching his eye with a fingernail while putting in contact lenses. The quest for easier ways to put in eye-drops lead to easier ways to put in contacts. He succeeded in blending these functions into a single device with 8 easy-to-use eye care methods (, dramatically changing the ways people use Eye-Drops and Contact Lenses. It quickly relieves dry/tired eyes. The design efficiencies significantly lower the costs of eye care..

The Eye~POD™ uses a self-actuating series of Liquid Affinity Physics that easily inserts/removes contacts Finger-Free in a split-second (no risky sticking unclean fingers in eyes), + applies single eye-drops; even gives liquid eye Massages. The Eye~POD Adapter's Tunnel-of-Light aligns contact lens/single eye-drop with the pupil of the eye, ensuring placement on exact center of eye.  Eliminates need to bend head backwards or use mirrors. Device never touches the eye itself. The low skill-level needed, plus never having to stick fingers on eyeballs, expands use of contacts, enabling folks who gave up on contacts to wear them again. Snap-on cover stores Adapter/liquid-capsules for a complete ready-to-use pocket portable kit.

It's the only device able to deliver one single eye-drop on the exact center of the eye without the need to bend over-a big help to those with arthritis, bad back/neck, vertigo. Eliminates costly drops wasted running down one's cheek. Many, especially the elderly, pay $50.-to-$200.+/ounce for medicated drops. It makes a 1/ounce bottle of eye-drops last up to a year, saving about 60% on eye-drops.

As a First Aid device, it quickly flushes outs foreign particles, relieves burning Itchy eyes fast, refreshes tired/dry eyes; quickly gets the 'red out' of bloodshot eyes. At $9.98, it offers easier, safer, lower-cost ways to manage Contacts, Eye-drops; various eye aggravations. Overall, the Eye~POD™ represents a significant advance in eye care products.


SEE demonstration:  National TV: 'The Product Network', Feb.25th, 7:30 AM-EST.  SEE also on The Product 8 PM-EST. To get ION TV Channel, Google: plus  zip-code.   Tivo it., Dr. Chuck, Hot Ideas World.

SOURCE Hot Ideas World Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. New Topical Therapy Safely Treats Serious Skin Infections Without Systemic Side Effects
2. Seriously Low Vaccination Rates Cause Experts to Call for Increased Immunization Before Influenza Season Peaks
3. Mayo Clinic Clarifies Diagnosis and Treatment for Rare, Serious Blood Vessel Disease of Brain and Spinal Cord
4. Despite Serious Health Risks, One in Three Adults with Heart Disease Does Not Believe They Need a Flu Shot This Year
5. Olympic Gold Medalist Kristi Yamaguchi Joins American Lung Association of Michigan to Address Seriously Low Vaccination Rates; Urge Metro-Detroiters to Get Immunized This Season
6. Simple Test Accurately Predicts Risk of Serious Jaundice in Newborns
7. Infant Formula Manufacturers Again under Ethical Cloud: Marketing Gimmick Linked to Serious Illnesses
8. Vermillion and the Ohio State University Report That Novel Diagnostic Test May Help Predict Risk for Relapse of TTP, A Serious Blood Disorder
9. The Largest Ever Study of Diabetes Shows Intensive Glucose Control Reduces Serious Complications
10. Omega-3 Fatty Acids Critical to Infants, Mothers and the Seriously Ill
11. VIA Pharmaceuticals Announces Positive Results of Phase 2 Studies of VIA-2291 in Patients With Serious Cardiovascular Disease
Post Your Comments:
(Date:11/25/2015)... THOUSAND OAKS, Calif. , Nov. 25, 2015 /PRNewswire/ ... of a Biologics License Application (BLA) with ... Administration (FDA) for ABP 501, a biosimilar candidate to ... the first adalimumab biosimilar application submitted to the FDA ... biosimilar pathway. Sean E. Harper , M.D., ...
(Date:11/25/2015)... On Tuesday, November 24, 2015, the ... Wright Medical Technology, Inc. for product liability and ... implant device, awarded $11 million in favor of ... and three days of deliberations, the jury found ... designed and unreasonably dangerous, and that Wright Medical ...
(Date:11/25/2015)... -- Allergan plc (NYSE: AGN ) today announced that ... York State Attorney General,s Office to end the ... statutes with the Attorney General over the decision of Forest ... selling the now generic version of memantine immediate release tablets.  ... released its counterclaims against New York , ...
Breaking Medicine Technology:
(Date:11/27/2015)... ... November 27, 2015 , ... According to an article ... the way that they are handling security in light of the recent terrorist attacks ... in an attempt to stop an attack from reaching U.S. soil. Especially around special ...
(Date:11/27/2015)... ... November 27, 2015 , ... A team of Swiss ... to treat it. Surviving Mesothelioma has just posted the findings on the website. ... Zurich analyzed the cases of 136 mesothelioma patients who were treated with chemotherapy followed ...
(Date:11/27/2015)... ... November 27, 2015 , ... "When ... said an inventor from Hillside, N.J. "Many people catch diseases simply from sitting ... individuals will always be protected from germs." , He developed the patent-pending QUDRATECS ...
(Date:11/27/2015)... ... ... The print component of “Supporting Our Caregivers” is distributed ... Minneapolis, South Florida, with a circulation of approximately 250,000 copies and an estimated ... media strategy and across a network of top news sites and partner media ...
(Date:11/27/2015)... ... ... MPWH, the No.1 Herpes-only dating community in the world, revealed that over 50% of its ... 3.7 billion people under the age of 50 – or 67% of the population - ... estimates of HSV-1 infection . , "The data shocks us highly!" said Michelle Li, ...
Breaking Medicine News(10 mins):